Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of different doses of
CAT-2003 in patients with hyperlipidemia when CAT-2003 is taken for 4 weeks. The study will
evaluate effects of CAT-2003 on (1) fasting triglycerides and non-HDL-C in patients with
moderate hypertriglyceridemia and (2) fasting LDL-C levels in combination with a statin in
patients with hypercholesterolemia who are on a statin.